Efforts have been made to develop inhibitors of the SHh pathway, including Vismodegib, a Smo inhibitor, as well as GANT-61, a Gli inhibitor that regulates Gli-dependent transcription, to promote anti-cancer activity [33, 34]. The gene discussed is SMO; the disease is cancer.